Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study
Main Authors: | Kajiura, Shinya, Hosokawa, Ayumu, Ueda, Akira, Mihara, Hiroshi, Ando, Takayuki, Fujinami, Haruka, Nishikawa, Jun, Ogawa, Kohei, Minemura, Masami, Sugiyama, Toshiro |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404649/ |
Similar Items
-
Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial
by: Ueda, Akira, et al.
Published: (2013) -
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
by: Ando, Takayuki, et al.
Published: (2015) -
Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study
by: Ogawa, Kohei, et al.
Published: (2012) -
The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment
by: Tanaka, Mizue, et al.
Published: (2014) -
Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm
by: Araki, Hiroshi, et al.
Published: (2012)